1. Home
  2. AMPH vs ULCC Comparison

AMPH vs ULCC Comparison

Compare AMPH & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

N/A

Current Price

$28.85

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Frontier Group Holdings Inc.

ULCC

Frontier Group Holdings Inc.

N/A

Current Price

$7.64

Market Cap

1.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
AMPH
ULCC
Founded
1996
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2005
2017

Fundamental Metrics

Financial Performance
Metric
AMPH
ULCC
Price
$28.85
$7.64
Analyst Decision
Hold
Hold
Analyst Count
7
12
Target Price
★ $24.50
$7.39
AVG Volume (30 Days)
415.9K
★ 4.2M
Earning Date
11-05-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.67
N/A
Revenue
$719,887,000.00
★ $3,724,000,000.00
Revenue This Year
$3.81
$33.78
Revenue Next Year
$4.91
$9.38
P/E Ratio
$17.10
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$16.65
$3.02
52 Week High
$31.00
$8.53

Technical Indicators

Market Signals
Indicator
AMPH
ULCC
Relative Strength Index (RSI) 64.24 62.77
Support Level $27.24 $5.42
Resistance Level $29.35 $8.36
Average True Range (ATR) 1.07 0.61
MACD 0.15 0.21
Stochastic Oscillator 61.97 77.32

Price Performance

Historical Comparison
AMPH
ULCC

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos, and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. The majority of revenue is from Domestic flight follow by International.

Share on Social Networks: